[Treatment of peptic ulcer and gastritis associated with Helicobacter pylori]

Enferm Infecc Microbiol Clin. 1995 Aug-Sep;13(7):422-8.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents / therapeutic use
  • Bismuth / therapeutic use
  • Chronic Disease
  • Drug Resistance, Microbial
  • Drug Therapy, Combination / therapeutic use
  • Duodenitis / drug therapy
  • Duodenitis / microbiology
  • Gastritis / complications
  • Gastritis / drug therapy*
  • Gastritis / microbiology
  • Helicobacter Infections / complications*
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori* / drug effects
  • Helicobacter pylori* / pathogenicity
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / etiology
  • Metronidazole / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / etiology
  • Salicylates / therapeutic use
  • Stomach Neoplasms / etiology

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Organometallic Compounds
  • Salicylates
  • Metronidazole
  • bismuth subsalicylate
  • Bismuth